General Information of Drug (ID: DMZM5KE)

Drug Name
arachidonylcyclopropylamide Drug Info
Synonyms arachidonyl cyclopropylamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
5311007
CAS Number
CAS 229021-64-1
TTD Drug ID
DMZM5KE

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
N-arachidonoylglycine DM85RJ1 Discovery agent N.A. Investigative [4]
O-1602 DM9VISB Discovery agent N.A. Investigative [3]
abnormal cannabidiol DMV6DAO Discovery agent N.A. Investigative [3]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [5]
NABILONE DMVRYT2 Insomnia 7A00-7A0Z Approved [6]
Orlistat DMRJSP8 Obesity 5B81 Approved [7]
SR141716A DMCO5JZ Obesity 5B81 Approved [8]
Tebipenem DMVSX6O Urinary tract infection GC08 Phase 3 [9]
Conatumumab DM2UOSN Colorectal cancer 2B91.Z Phase 2 [10]
GW-42004 DMY3KSU Lipid metabolism disorder 5C52.Z Phase 2 [11]
SR-147778 DMNAECP Obesity 5B81 Phase 2 [12]
Nimacimab DM21Z68 Diabetic nephropathy GB61.Z Phase 2 [13]
AEF0117 DMQ1GH4 Marijuana use disorder 6C41 Phase 2 [14]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cannabinoid receptor 1 (CB1) TT6OEDT CNR1_HUMAN Agonist [2]
N-arachidonyl glycine receptor (GPR18) TTSLJAR GPR18_HUMAN Agonist [3]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 739).
2 Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther. 1999 Jun;289(3):1427-33.
3 Delta(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br J Pharmacol. 2012 Apr;165(8):2414-24.
4 Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun. 2006 Sep 1;347(3):827-32.
5 Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol. 2009 Feb;156(3):397-411.
6 Novel 1',1'-chain substituted hexahydrocannabinols: 9-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid r... J Med Chem. 2010 Oct 14;53(19):6996-7010.
7 Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. J Med Chem. 2008 Nov 13;51(21):6970-9.
8 Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50.
9 Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.
10 Clinical pipeline report, company report or official report of AstraZeneca (2009).
11 Company report (Gwpharm)
12 Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits 9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans.Br J Clin Pharmacol.2013 Jul;76(1):65-77.
13 Clinical pipeline report, company report or official report of Bird Rock Bio.
14 Clinical pipeline report, company report or official report of Affimed Therapeutics.